866-997-4948(US-Canada Toll Free)

Cervical Cancer Global Clinical Trials Review, H1, 2017

Published By :

GlobalData

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 504 Pages

Cervical Cancer Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, Cervical Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Cervical Cancer to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Cervical Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Cervical Cancer 31
Jun 02, 2017: Opdivo (nivolumab) Data in Patients with Advanced Cervical, Vaginal and Vulvar Cancers from Phase 1/2 CheckMate -358 Presented at ASCO 31
May 18, 2017: Advaxis to Host Investor & Analyst Day on June 12 31
Apr 18, 2017: Lion Biotechnologies Highlights Publication of New Translational Data in Science for TIL Therapy for Treatment of Cervical Cancer 32
Mar 27, 2017: Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac 32
Mar 23, 2017: Vaccibody Announces Vaccination Of First Patient In Its Phase IIA Study With VB10.16 Immunotherapy For Patients With HPV16 Induced High Grade Lesions Of The Cervix 32
Mar 15, 2017: Advaxis Presents Oral Late-breaking Data on Phase 2 GOG-0265 Study of Axalimogene Filolisbac at SGOs Annual Meeting on Womens Cancer 33
Clinical Trial Profile Snapshots 35
Appendix 502
Abbreviations 502
Definitions 502
Research Methodology 503
Secondary Research 503
About GlobalData 504
Contact Us 504
Disclaimer 504
Source 504

List of Tables
Cervical Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 8
Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Cervical Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
Cervical Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Cervical Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Cervical Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Cervical Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Cervical Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Cervical Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Cervical Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Cervical Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Cervical Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Cervical Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Cervical Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Cervical Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Cervical Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Cervical Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Cervical Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Cervical Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Cervical Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Cervical Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Cervical Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Cervical Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 503

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *